Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Research Study Design: Comparison of Tracking Protocols

Dermal Wound Repair Epithelialisation %, collagen I/III ratio, capillary density (CD31+ per mm²) 0, 3, 7, 14, 21 Saline vehicle control, wound size standardisation, identical excision depth Wound closure rate (mm²/day), collagen density (μg/mg tissue) Best for

This comparison does not assign a generated winner or score.

  • Dermal Wound Repair
  • Epithelialisation %, collagen I/III ratio, capillary density (CD31+ per mm²)
  • 0, 3, 7, 14, 21
  • Saline vehicle control, wound size standardisation, identical excision depth
  • Wound closure rate (mm²/day), collagen density (μg/mg tissue)
  • Best for TB-500 angiogenic mechanism demonstration. Short study duration, clear quantitative endpoints
  • Tendon/Ligament Injury
  • Tensile strength (MPa), collagen fibre alignment (polarised light), MMP-2 expression
  • 0, 7, 14, 21, 28
  • Sham injury control, mechanical load standardisation, contralateral limb baseline
  • Load-to-failure force (Newtons), elastic modulus (MPa)
  • Gold standard for functional outcome validation. Mechanical testing proves biological relevance
  • Myocardial Infarction Model
  • Ejection fraction (%), infarct size (% LV), capillary density, cardiomyocyte apoptosis rate
  • 0, 7, 14, 28
  • Sham surgery control, infarct location standardisation, echocardiography timing
  • Fractional shortening (%), scar tissue area (mm²)
  • Clinically relevant but requires advanced imaging. TB-500 cardiac data strongest in this model
  • Skeletal Muscle Strain
  • Contractile force recovery (% baseline), inflammatory cell infiltration, satellite cell activation (Pax7+ cells)
  • 0, 3, 7, 14
  • Contralateral muscle control, strain severity grading, force measurement protocol
  • Peak tetanic force (N), cross-sectional area recovery (%)
  • Fastest measurable outcomes. TB-500 effects detectable by day 7 in published studies
  • This table shows that TB-500 research outcomes tracking is not a one-size protocol. The biomarkers, timepoints, and controls depend entirely on the injury model. Dermal studies can capture meaningful data in 14–21 days; tendon studies require 28+ days to measure mechanical strength recovery. The 'Professional Assessment' column highlights which models provide the clearest causality demonstration: mechanical testing in tendon studies and ejection fraction in cardiac models leave little room for subjective interpretation.
More references

Related material